AtriCure Q1 FY26 swings to profit of $108,000; revenue rises 14.3% to $141.25 million

AtriCure, Inc.

AtriCure, Inc.

ATRC

0.00
  • AtriCure posted net income of USD 108,000 as revenue rose 14.3% to USD 141.25 million.
  • Operating income swung to USD 526,000 from an operating loss, while gross margin widened 2.46 percentage points to 77.4%.
  • Research and development expenses increased 7.6% to USD 24.24 million, while selling, general and administrative costs climbed 11.2% to USD 84.55 million.
  • Pain management revenue jumped 29.5% to USD 22.36 million, while minimally invasive ablation revenue fell 24.7% to USD 6.39 million.
  • Received CE mark approval under EU MDR for AtriClip FLEX-Mini and PRO-Mini devices in April 2026, with a European launch expected later this year.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AtriCure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001323885-26-000023), on May 06, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.